PHYSIOTHERAPY BASED APPROACHES TO PATIENT REHABILITATION AND DENTAL EXPERTISE FOR JAW AND FACIAL PAIN
With
Darron Goralsky,
CEO & Clinical Director
Melbourne TMJ & Facial Pain Centre
PEOPLE IN HEALTH CARE SEGMENT
Filmed in Melbourne | November 2025
Darron Goralsky is the Founder, CEO and Clinical Director of Melbourne TMJ & Facial Pain Centre, one of Australia’s leading multidisciplinary clinics dedicated to the assessment and management of temporomandibular disorders (TMD) and craniofacial pain.
With over 30 years of experience treating TMJ, facial and neck-related conditions, Darron originally trained as a Physiotherapist in South Africa, completing post graduate certifications in Manipulative Therapy. After his arrival in Melbourne he then continued with studies in Craniosacral Therapy. Early in his career, Darron identified a major gap in how jaw and facial pain conditions were managed—recognising the need for a collaborative approach that integrates manual therapy and other physiotherapy based approaches to patient rehabilitation, and dental expertise.
This insight led to the development of the Goralsky Craniomandibular Method (GCMM), a structured multidisciplinary protocol combining physiotherapy principles with dental and medical collaboration. Darron has lectured to many dental and allied health groups, was part of a 4 person lecture team for a one day course on TMD for the University of Melbourne’s Dental School, and presented at the 2019 ANZAOP Conference. In 2024, Darron was an invited speaker at the Myofocus Functional Health Symposium in Melbourne, presenting on multidisciplinary management of TMD and orofacial pain. Darron has also presented a 5-hour Masterclass for dentists as part of Dr Damian Teo’s Mini Residency in TMD & Sleep for the last 5 years. Building on this momentum, he developed and successfully delivered his inaugural 2-day intensive professional education program for dental professionals, The 5-Step TMD Protocol Course, in October 2025.
A passionate educator and mentor, Darron now focuses on training and developing clinicians in his evidence-based approach. His growing team includes TMJ physiotherapists, osteopaths, dentists, and orofacial myofunctional therapists, a breathing educator and a GP working collaboratively to deliver comprehensive patient care. Darron is an active member of the Australian Physiotherapy Association (APA), the American Academy of Craniofacial Pain (AACP), and the Australia and New Zealand Academy of Orofacial Pain (ANZAOP).
Source: Supplied and adapted
-
New research papers show productivity gains and gaps
Commissioner Catherine De Fontenay talks about the Productivity Commission’s new approach to analysing health productivity, shifting the perspective from the unit measurement of individuals using the health system to the actual improvement of health. This has shown Australia’s health treatment productivity is improving, but identifies gaps in preventative health measures and duplication, where digital technology needs to be more effectively used.
-
Addressing Wound Management
The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
-
Medicinal cannabis in Australia Update
According to the Australian Journal of General Practice, published by the Royal Australian College of General Practitioners, more than 130,000 medicinal cannabis approvals have been issued in Australia to date, mostly by general practitioners, with approximately 65% of these to treat chronic non-cancer pain. Despite robust supportive data from animal models, current clinical trial evidence for THC and CBD efficacy in chronic pain is incomplete. In their prescribing decisions, doctors must balance patient demand and curiosity with caution regarding potential risks and limited efficacy (Source: https://www1.racgp.org.au/ajgp/2021/october/medicinal-cannabis)
Australian Health Journal met with 3 speakers at the recent @arcsaustralia ARCS22 Conference providing an update on medicinal cannabis. The discussion with the speakers now centres on affordability and access.
